13.15
-2.07 (-13.60%)
| Penutupan Terdahulu | 15.22 |
| Buka | 14.42 |
| Jumlah Dagangan | 1,162,481 |
| Purata Dagangan (3B) | 635,057 |
| Modal Pasaran | 569,846,016 |
| Harga / Jualan (P/S) | 12.00 |
| Julat 52 Minggu |
| Margin Keuntungan | -104.64% |
| Margin Operasi (TTM) | -65.71% |
| EPS Cair (TTM) | -1.30 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 440.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 22.21% |
| Nisbah Semasa (MRQ) | 4.62 |
| Aliran Tunai Operasi (OCF TTM) | -40.34 M |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Bercampur |
| Medical Devices (Global) | Menurun | Bercampur | |
| Stok | Beta Bionics, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.0 |
| Purata | 0.88 |
|
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product include the iLet Bionic Pancreas (iLet). The Company operates as single segment, focused on the development, manufacture and sale of the iLet. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| % Dimiliki oleh Orang Dalam | 7.52% |
| % Dimiliki oleh Institusi | 57.74% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 06 May 2025 | Pengumuman | Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 |
| 01 May 2025 | Pengumuman | Beta Bionics to Present at the Bank of America Securities Health Care Conference |
| 16 Apr 2025 | Pengumuman | Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 |
| 09 Apr 2025 | Pengumuman | Beta Bionics to Host Investor Event on June 22, 2025 |
| 27 Mar 2025 | Pengumuman | Beta Bionics Announces Board Appointment of Gerard Michel |
| 25 Mar 2025 | Pengumuman | Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 |
| 27 Feb 2025 | Pengumuman | Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |